NCT01060969View on ClinicalTrials.gov

Tadalafil and Acetazolamide Versus Acetazolamide in Acute Mountain Sickness Prevention

NACompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Pulmonary EdemaCerebral Edema
Interventions
DRUG

Tadalafil and acetazolamide

Experimental arm: Tadalafil 20 mg daily + acetazolamide 125 mg BID beginning above 3000 m altitude.

DRUG

Acetazolamide

Active comparator arm (control): acetazolamide 125 mg BID beginning above 3000 m altitude

Trial Locations (3)

Unknown

Center of Geographic Medicine, Tel Litwinsky

Sheba Medical Ctr., Tel Litwinsky

Tel Litwinsky

All Listed Sponsors
lead

Sheba Medical Center

OTHER_GOV

NCT01060969 - Tadalafil and Acetazolamide Versus Acetazolamide in Acute Mountain Sickness Prevention | Biotech Hunter | Biotech Hunter